Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2049
http://purl.obolibrary.org/obo/NCIT_C2049
|
|---|---|
| Preferred Name | Indibulin |
| Definitions |
A synthetic small molecule with antimitotic and potential antineoplastic activities. Indibulin binds to a site on tubulin that is different from taxane- or Vinca alkaloid-binding sites, destabilizing tubulin polymerization and inducing tumor cell cycle arrest and apoptosis. This agent has been shown to be active against multidrug-resistant (MDR) and taxane- resistant tumor cell lines.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic small molecule with antimitotic and potential antineoplastic activities. Indibulin binds to a site on tubulin that is different from taxane- or Vinca alkaloid-binding sites, destabilizing tubulin polymerization and inducing tumor cell cycle arrest and apoptosis. This agent has been shown to be active against multidrug-resistant (MDR) and taxane- resistant tumor cell lines. |
|---|---|
| prefLabel | Indibulin
|
| label | Indibulin
|
| PDQ_Closed_Trial_Search_ID | 587341
|
| code | C2049
|
| prefixIRI | NCIT:C2049
|
| in_subset | |
| Preferred_Name | Indibulin
|
| FDA_UNII_Code | 80K4H2RB8P
|
| Contributing_Source | FDA
|
| Chemical_Formula | C22H16ClN3O2
|
| Maps_To | Indibulin
|
| CAS_Registry | 204205-90-3
|
| NCI_Drug_Dictionary_ID | 587341
|
| Legacy Concept Name | D_24851
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 587341
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C1956330
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |